Takashi Kojima

National Cancer Center Hospital East

Papers

1

Total Citations

21

H-Index

1

About

Dr. Takashi Kojima is a leading figure in esophageal cancer surgery, whose work has significantly advanced the field of minimally invasive esophagectomy. His primary research focuses on comparing surgical techniques to improve patient outcomes, with a particular emphasis on the short-term benefits of robotic-assisted procedures. In his highly cited 2022 study, Kojima conducted a rigorous propensity-matched analysis of 189 patients, directly comparing robot-assisted minimally invasive esophagectomy (RAMIE) to conventional thoracoscopic esophagectomy (MIE). This landmark work, which has garnered 21 citations, demonstrated the superior short-term outcomes of RAMIE, providing crucial evidence for the adoption of robotic techniques in thoracic esophageal cancer treatment. By meticulously evaluating surgical approaches, Kojima has helped define best practices and reduce postoperative complications. His contributions are instrumental in shaping modern surgical protocols, offering patients safer, more effective options. Through his focused, data-driven research, Dr. Kojima continues to drive innovation in oncologic surgery, making a tangible impact on the field and the lives of those affected by esophageal cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
Propensity‐Matched Analysis of the Short‐Term Outcome of Robot‐Assisted Minimally Invasive Esophagectomy Versus Conventional Thoracoscopic Esophagectomy in Thoracic Esophageal Cancer
21 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: National Cancer Center Hospital East

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago